CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Profit & Loss Account Balance | ₹644 Cr | ₹504 Cr | ₹378 Cr | ₹306 Cr |
What is the latest Profit & Loss Account Balance ratio of CORONA REMEDIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹644 Cr |
| Mar2025 | ₹504 Cr |
| Mar2024 | ₹378 Cr |
| Mar2023 | ₹306 Cr |
How is Profit & Loss Account Balance of CORONA REMEDIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹644 Cr | 27.90 | |
| Mar2025 | ₹504 Cr | 33.35 | |
| Mar2024 | ₹378 Cr | 23.51 | |
| Mar2023 | ₹306 Cr | - | |
Compare Profit & Loss Account Balance of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,815.6 Cr | -0.8% | 2.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -0.8% |
2.3% |
|
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses